Daily Vitamins private label for UK brands

The UK runs no central notification step for a Daily Vitamins range at all — food business operator responsibility sits with the brand directly under Retained EU Law, a starting point closer to the Netherlands' operator-responsibility model than to a market with its own filing body. What makes the UK different from every other market in this registry is what has happened to that inherited EU baseline since: the FSA's own novel-food list has started to diverge from the EU's, and nutrient-labelling figures and allergen formatting have begun to drift from their EU-aligned starting point too.

UK retail for Daily Vitamins runs mainly through Boots and Holland & Barrett, anchoring both the pharmacy and the specialist health-retail channel, alongside grocery and a scaled direct-to-consumer line. Pharmacist gate-keeping at Boots in particular shapes which claim phrasing actually clears the shelf, a retailer-level filter that sits on top of the FSA/DHSC baseline rather than replacing it.

For a brand treating a UK range as a straightforward EU-adjacent extension, the post-Brexit divergence in novel-food status and label formatting is the detail most likely to catch a formula or label out — worth checking against the current FSA position rather than an older EU-aligned assumption.

Ashwagandha Gummies, pairing withania somnifera root extract with pyridoxine hydrochloride, and Berberine Gummies, built on berberine HCL and mulberry leaf, give a UK range two single-active SKUs suited to Holland & Barrett's specialist-retail shelf as much as a Boots pharmacy counter. Multivitamin Gummies and Daily Nutrition Pack Sachets form the foundational pair behind them — the gummy built on retinyl acetate, vitamin E (d-alpha-tocopherol) and d-biotin, the sachet carrying a wider combination of those same actives plus menaquinone-7, B-complex and choline bitartrate in a flatter pack. Magnesium Citrate Gummies, built on pyridoxine hydrochloride, and Fibre + Prebiotic Gummies, formulated with chicory root extract, round out a UK assortment once the FSA novel-food position on each active is confirmed.

There's no single filing body to check a UK launch against, which makes confirming the FSA's current post-Brexit position — rather than an inherited EU one — the first item worth settling, ahead of sampling and English-language artwork.

• Check FSA's current novel-food position, not the EU's. Since the FSA's novel-food list now diverges from the EU's, confirming each active's UK status alongside sample evaluation avoids a formula assumption that no longer holds.
• English-language artwork, built for Boots and Holland & Barrett gate-keeping. Label copy, on-pack text and retail packaging for the UK market are written in English, with claim phrasing worth drafting against what actually clears Boots' pharmacist review and Holland & Barrett's shelf.
• Keep personalisation inside Make it Yours. That route reaches flavour, colour and format on an existing formula, not actives, dosage or claims — those move a project into Custom Formula R&D, with format and pack size confirmed per project either way.
• Compliance stays with the brand owner. With no central body clearing a UK filing, claims, labelling and ongoing market compliance rest with the brand from the first pack run onward, not just after a range reaches Boots or Holland & Barrett.